Comparison

Balicatib European Partner

Item no. TMO-T1850-500mg
Manufacturer TargetMol
CASRN 354813-19-7
Amount 500 mg
Quantity options 100 mg 1 mL x 10 mM (in DMSO) 10 mg 1 mL 200 mg 25 mg 2 mg 500 mg 50 mg 5 mg
Category
Type Inhibitors
Specific against other
Smiles CCCN1CCN(CC1)c1ccc(cc1)C(=O)NC1(CCCCC1)C(=O)NCC#N
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Alias AAE581
Shipping Condition Cool pack
Available
Manufacturer - Targets
Cysteine Protease
Shipping Temperature
Cool pack
Storage Conditions
-20
Molecular Weight
411.54
Description
Balicatib (AAE581) is a potent and selective inhibitor of cathepsin K, used in trials studying the treatment of osteoporosis.
Pathways
Proteases/Proteasome

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 500 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close